Your English writing platform
Discover LudwigExact(60)
More subjects will be added over time "based on user feedback and demand".
More subjects who received erenumab achieved ≥50% reduction in MMD in both subgroups compared with placebo.
More subjects and clinical studies with control groups will be necessary to validate these measurements.
More subjects reported discomfort following squat and a preference for stoop.
More subjects initiated NSAID than GPA therapy.
More subjects listed BAR (34%) than the other three illustrations.
More subjects were appropriately reclassified for diabetes risk.
More subjects with atopy were included in the Swedish cohort.
"The more subjects we do, the more subjects are revealed to us".
More than 80% were set for three or more subjects.
In future, more subjects are likely to be jointly taught.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com